Daily ShareChat: Nuplex Industries
By Jenny Ruth
Resins manufacturer Nuplex benefited from strong margin gains in the six months ended December because of the raw materials tailwinds in 2009 but those gains could unwind in 2011, says Dennis Lee, an analyst at Craigs Investment Partners.
Nuplex's EBITDA (earnings before interest, tax, depreciation and amortisation) margins expanded by 420 basis points in the six months ended December which Lee doesn't think is sustainable.
Since the end of December, "the average raw materials cost has risen 15% while product pricing continues to be hampered by the low industry utilisation rate, currently about 75%," Lee says.
"Unless we see a strong macro recover, the volume run-rate will start to normalise as restocking activity and government stimulus roll off," he says. The company's regional diversity should help cushion it against some of the margin erosion.
Lee is forecasting Nuplex's 2011 earnings will be flat, reflecting the benefit of better cost absorption after restructuring.
He views Nuplex's acquisition of Med-Chem as "an excellent bolt-on acquisition" which is likely to add 2.1 per cent to 2011 EBITDA. The undisclosed price is unlikely to have exceeded $10 million which implies a three-year payback.
While he sees little near-term upside potential for Nuplex's share price, "the downside also looks limited."
BROKER CALL: hold
Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.
Comments from our readers
No comments yet Add your comment:
Related News
Nuplex enters Russian joint venture Nuplex shares plunge 7.8% after profit warning Nuplex gains regulatory approval for Viverso purchase Nuplex may replace some bank debt with first issue of bonds in US private placement market Nuplex to buy Bayer MaterialScience's Viverso, forecasts 10% earnings growth Nuplex bows to shareholder pressure, withdraws director fee hike proposal Nuplex directors ask for shareholders for 33% pay rise Nuplex pays A$23.5 mln for Acquo Masterbatch Nuplex full year profit up 7.5 pct Daily ShareChat: Nuplex
NZX Annoucements for NPX
|
|
Nuplex Industries Limited Ordinary Shares
Current quote:
NPX $2.61 +1
Quotes delayed 20 minutes
Price when article published: $3.35
Previous News
FREE Email News
Stock Quote
Today's Market Numbers
| NZX 50 Index |
3326.74 |
 |
2.10 |
| S&P/ASX 200 |
4282.90 |
 |
7.80 |
| Dow Jones Industrials |
12884.00 |
 |
5.80 |
Most Commented On
|
|


NZX 15 Index
|